Oncolytics Biotech Collaborators to Present Survival Data from REO 016 Study in NCLC at IASLC

By: via Benzinga
Oncolytics Biotech Inc. (NASDAQ: ONCY) today announced that Dr. Miguel A. Villalona-Calero will make an oral presentation at ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.